SARASOTA, FL, UNITED STATES, January 28, 2026 / EINPresswire.com / — Identifyn ®, a leader in super-resolution applications ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

The global market for synthetic chemicals is witnessing a strategic realignment, driven by shifting supply chains, heightened ...

"Lower dose does not mean lower responsibility." ...

Altimmune stock: 48-week pemvidutide MASH data, FDA Breakthrough Therapy boost, but rising competition and cash needs. Click ...

At Healthline, we’re committed to providing you with trustworthy, accessible, and accurate information so you’re equipped to care for your health and wellness. We use an established Editorial Process ...

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...

Trump says he doesn't know if he backs constitutional due process rights in new interview President Donald Trump is circumspect about his duties to uphold due process rights laid out in the ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

One of the persistent challenges in precision oncology is the fact that most advanced cancers are complex and highly individualized. A recent ...

Disclaimer: This article is for informational purposes only. It is not medical advice. Weight management concerns should be ...